Best Medication for Social Anxiety: A Guide to Your Treatment Options
Author:
Blossom Editorial
Social anxiety disorder (SAD) can turn ordinary moments, like speaking up in a meeting or meeting someone new, into sources of intense fear. If you struggle with this condition, there are effective treatment options available, including cognitive behavioral therapy (CBT), medication, or both. This guide walks through the best medications for social anxiety, how they work, what the dosing looks like, and how to decide with a provider which option may fit you.
Key Takeaways
Social anxiety is common: The National Institute of Mental Health (NIMH) estimates that about 7.1% of U.S. adults have social anxiety disorder in a given year, while about 12.1% experience it at some point in their lives. These estimates come from a large national survey conducted in the early 2000s. The condition is more common in women than men and is treatable with medication, therapy, or both.
SSRIs and an SNRI are effective treatment options: Some SSRIs and the SNRI venlafaxine (Effexor) are the best-supported medication options for social anxiety disorder, although many guidelines recommend cognitive behavioral therapy as a first-line treatment in appropriate patients.
Give it time and guidance: Medications often take several weeks to begin helping, and your provider may give them around 10–12 weeks at an appropriate dose before deciding whether they are working well enough.
What is Social Anxiety Disorder?
Social anxiety disorder, sometimes called social phobia, is a strong and persistent fear of being judged, embarrassed, or rejected in social or performance situations. It goes well beyond ordinary shyness. People with social anxiety often avoid the situations they fear, which can quietly shrink their world over time and affect school, work, and relationships. The symptoms can look different from person to person, and it is one of several anxiety disorders with effective treatment options, including CBT and medication.
It is also one of the most common anxiety conditions. According to the National Institute of Mental Health, around 12.1% of American adults experience social anxiety disorder at some point in life. Social anxiety often begins in the teen years, can occur alongside depression or other anxiety disorders, and tends to go undertreated because many people assume the fear is just part of who they are. In fact, the presence of a comorbid condition is what leads people with social anxiety disorder to seek treatment sooner.
This needn’t have to be the case, though. Comorbidities in SAD are associated with more severe symptoms and impairment, so if you think you may have social anxiety, it is advisable to consult a licensed psychiatric provider rather than struggle with it. Recognizing social anxiety disorder as a treatable condition is an important first step.
How Do Medications for Social Anxiety Work?
Most first-line medications for social anxiety are antidepressants that modulate serotonin pathways over time. Serotonin is a brain chemical involved in many functions such as mood, sleep, anxiety, and digestion. By regulating this system over several weeks, they can lower baseline anxiety and make feared situations feel less overwhelming.
The antidepressants approved by the U.S. FDA for treating social anxiety disorder include the selective serotonin reuptake inhibitors (SSRIs) sertraline (Zoloft) and paroxetine (Paxil) and the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine (Effexor XR). Other SSRIs, including escitalopram (Lexapro) and fluoxetine (Prozac), may be prescribed off-label in some cases.
Treatment for social anxiety usually involves either CBT or medication. Some people benefit from using them together. The sections below break down the leading options, starting with those approved specifically for social anxiety.
Best Medications for Social Anxiety
No single medication is best for everyone. The right fit depends on your symptoms, health history, other medications, and how your body responds. Here are the options providers turn to most often.
Sertraline (Zoloft)
Sertraline is an SSRI that is FDA-approved for social anxiety disorder and is a commonly prescribed option. For social anxiety, it is usually started around 25 mg daily and increased gradually as needed, up to a maximum of 200 mg daily. Common early side effects include nausea, sleep changes, and headache, which often ease within the first couple of weeks.
Paroxetine (Paxil)
Paroxetine was the first SSRI approved for social anxiety and remains a well-studied choice. The FDA prescribing information supports its use for the condition, and clinical guidance lists it among the first-line agents with proven benefit. It comes in immediate-release and controlled-release forms, both of which are approved. The recommended starting dosage for paroxetine (immediate-release) is 20 mg/day. Although doses up to 60 mg/day are generally considered safe, clinical trials did not show any added benefit at doses higher than 20 mg daily.
Although paroxetine can be very effective, it can cause drowsiness or weight changes in some people, so it is worth discussing these potential side effects with your provider.
Venlafaxine (Effexor XR)
Venlafaxine (Effexor XR) extended-release is an SNRI. It is the one SNRI that is FDA-approved for social anxiety disorder and is often considered when an SSRI has not provided enough relief. It is usually started at a lower dose and increased gradually; the FDA-labeled studies for SAD used doses ranging from 75 to 225 mg per day. Because it affects norepinephrine in addition to serotonin, providers sometimes monitor blood pressure, especially at higher doses.
Other SSRIs
Beyond the options above, providers frequently use other SSRIs for social anxiety. Escitalopram (Lexapro) and fluoxetine (Prozac) are two SSRIs that are commonly prescribed off-label. Off-label simply means the medication is not formally approved for this exact use, not that it is unsafe or unhelpful, and many medications work well off-label when guided by a prescriber. These medications may be considered based on their evidence, side-effect profiles, other health conditions, and potential drug interactions.
Propranolol for Performance Anxiety
Propranolol is a beta-blocker sometimes used off-label for specific performance situations that can trigger anxiety, such as public speaking or a musical audition. Rather than treating anxiety broadly, it may reduce the physical signs of anxiety, like a racing heart and trembling, when taken 1-2 hours before an event. The use of propranolol is limited to occasional performance anxiety, since the evidence for beta-blockers in anxiety disorders is limited.
Options to Use With Caution (Benzodiazepines)
Benzodiazepines such as xanax (Alprazolam) and lorazepam (Ativan) are other off-label options that can ease anxiety quickly, but they carry a risk of dependence and are usually reserved for short-term or occasional use rather than long-term treatment of social anxiety.
Other medications, such as buspirone (Buspar) and certain nerve pain medications, have been studied for social anxiety, but they are not routine first-line treatments and may be considered only in selected situations. If avoiding dependence is a priority for you, it helps to explore non-addictive anxiety medication options with your provider.
Social Anxiety Medications Compared
The table below summarizes the main options, their drug class, and whether they are approved specifically for social anxiety disorder.
Medication | Class | FDA-approved for SAD | Notes |
|---|---|---|---|
Sertraline (Zoloft) | SSRI | Yes | Common first choice; 25 to 200 mg daily |
Paroxetine (Paxil) | SSRI | Yes | First SSRI approved for social anxiety; 20-60 mg/day |
Venlafaxine XR (Effexor XR) | SNRI | Yes | Only SNRI approved for social anxiety; 75-225 mg/day |
Escitalopram, Fluoxetine | SSRI | Off-label | Commonly used with strong track records |
Propranolol | Beta-blocker | Off-label | For performance situations, not daily use |
How Long Do Social Anxiety Medications Take to Work?
The SSRI and SNRI medications approved for social anxiety disorder can take several weeks to work. The clinical trials that demonstrated their effectiveness lasted 12 weeks or longer. Your provider may prescribe a medication for around 10 to 12 weeks at an appropriate dose before deciding whether it is helping enough.
If you see little improvement after several weeks at a steady dose, your provider may adjust the dose or try a different medication. Stopping suddenly can cause uncomfortable discontinuation symptoms, so any changes should be made with medical guidance.
Common Side Effects to Know About
Many people can take SSRIs and SNRIs without serious problems, but side effects vary from person to person and can sometimes persist. Knowing what may come up can make the first weeks less worrying.
Early adjustment effects: Nausea, headache, and changes in sleep are common in the first week or two and usually fade as your body adjusts.
Sexual side effects: Some people notice changes in libido or arousal; this is worth discussing openly with your provider, as options exist.
Activation or jitteriness: Some people experience increased anxiety, restlessness, or agitation when starting an antidepressant, which is one reason providers may begin with a lower dose and increase it gradually.
Discontinuation symptoms: Stopping or changing the dose suddenly can cause dizziness or flu-like feelings, so tapering under provider’s guidance is important.
If a side effect is severe or does not improve, tell your provider. Adjusting the dose or switching medications may help reduce bothersome side effects while maintaining treatment..
Medication and Therapy Together
Many guidelines recommend treating social anxiety disorder with individual CBT due to its large effect size and lower risk of side effects. In situations when therapy is not feasible, medication offers an evidence-based treatment approach. It also helps to know that while medication may offer faster results, therapy provides longer-lasting results. In some cases, especially when medication has only produced a partial response, a provider may consider adding therapy. However, at this point, there isn’t sufficient evidence that combined treatment is better than medication or therapy alone.
What If the First Medication Does Not Work?
It is common to need more than one try to find the right fit, and that is not a failure. If a first medication does not provide enough improvement after an adequate trial at an appropriate dose, a provider may adjust the dose, switch to another SSRI or to venlafaxine, or add CBT. Because social anxiety can occur alongside depression or other anxiety disorders, treating the coexisting condition can also improve results. The goal is steady progress, guided by someone who knows your history.
Start Social Anxiety Treatment With Blossom
Blossom is a telehealth platform that connects you with board-certified, licensed psychiatric providers for virtual care covered by in-network insurance.
If social anxiety is holding you back, you can begin from home in three simple steps: enter your state and insurance, choose a time that works for you, and confirm a few details.
During your virtual visit, your provider will evaluate your symptoms, build a plan, and prescribe medication when it is appropriate. Most people are seen within days. When you are ready, you can book your first appointment and take a real step toward feeling more at ease.
When to Seek Help
Consider reaching out if fear of social situations causes real distress or leads you to avoid work, school, or the people and activities you care about. You do not have to push through it alone. A provider can help you find the treatment that works for you. You deserve support, and relief is possible.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Never start or stop a medication without talking to your healthcare provider. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
National Institute of Mental Health. (n.d.). Social anxiety disorder. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/statistics/social-anxiety-disorder
Rose GM, Tadi P. Social Anxiety Disorder. [Updated 2022 Oct 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555890/
Koyuncu, A., İnce, E., Ertekin, E., & Tükel, R. (2019). Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges. Drugs in context, 8, 212573. https://pmc.ncbi.nlm.nih.gov/articles/PMC6448478/
U.S. Food and Drug Administration. (2023). Zoloft (sertraline hydrochloride) tablets and oral solution: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf
U.S. Food and Drug Administration. (2024, November). Paxil (paroxetine) tablets and oral suspension: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf
U.S. Food and Drug Administration. (2023, August). Effexor XR (venlafaxine hydrochloride) extended-release capsules: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf
National Institute for Health and Care Excellence. (2024). Social anxiety disorder: Recognition, assessment and treatment (CG159). https://www.ncbi.nlm.nih.gov/books/NBK612073/pdf/Bookshelf_NBK612073.pdf
Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K., Clark, D. M., Ades, A. E., & Pilling, S. (2014). Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. The lancet. Psychiatry, 1(5), 368–376. https://pmc.ncbi.nlm.nih.gov/articles/PMC4287862/
Melaragno, A. J. (2021). Pharmacotherapy for anxiety disorders: From first-line options to treatment resistance. FOCUS: The Journal of Lifelong Learning in Psychiatry, 19(2), 145–160. https://psychiatryonline.org/doi/10.1176/appi.focus.20200048
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013). The evidence-based pharmacotherapy of social anxiety disorder. International Journal of Neuropsychopharmacology, 16(1), 235–249. https://academic.oup.com/ijnp/article/16/1/235/629354
